320-detector Computed Tomography to Assess Myocardial Extracellular Volume Fraction in Patients With Atrial Fibrillation Before AF Ablation.
Sponsor: Canon Medical Systems, USA
This NA trial investigates Atrial Fibrillation and is currently actively recruiting participants. Canon Medical Systems, USA leads this study, which shows 11 recorded versions since 2025 — indicating substantial longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
11 versions recorded-
May 2025 — Present [monthly]
Recruiting NA
-
Apr 2025 — May 2025 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Feb 2025 — Apr 2025 [monthly]
Not Yet Recruiting NA
-
Jan 2025 — Feb 2025 [monthly]
Not Yet Recruiting NA
-
Dec 2024 — Jan 2025 [monthly]
Not Yet Recruiting NA
▶ Show 6 earlier versions
-
Nov 2024 — Dec 2024 [monthly]
Not Yet Recruiting NA
-
Oct 2024 — Nov 2024 [monthly]
Not Yet Recruiting NA
-
Sep 2024 — Oct 2024 [monthly]
Not Yet Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Not Yet Recruiting NA
-
May 2024 — Jul 2024 [monthly]
Not Yet Recruiting NA
-
Apr 2024 — May 2024 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Canon Medical Systems, USA
- Johns Hopkins University
For direct contact, visit the study record on ClinicalTrials.gov .